Estudo randomizado | Tenecteplase vs. alteplase para tratamento de AVC isquêmico agudo.

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial – The Lancet Neurology (link para o resumo – $ para o texto completo)

Comentário: Tenecteplase yields worse safety and functional outcomes compared to alteplase in ischaemic stroke: Lancet – Medical Dialogues